Please login to the form below
rights
This page shows the latest rights news and features for those working in and with pharma, biotech and healthcare.
AbbVie exits Voyager alliance for Alzheimer’s/Parkinson’s gene therapies
This included handing back the rights to a number of candidates, including a potential Parkinson’s treatment and gene therapies for Huntington disease, Friedreich’s ataxia and spinal muscular atrophy. ... Neurocrine picked up rights to the programme
Latest news
-
UK will provide millions of 90-minute COVID-19 tests over the coming months
The fact these tests can detect flu as well as COVID-19 will be hugely beneficial as we head into winter, so patients can follow the right advice to protect themselves
-
Roche pays $120m upfront for UCB’s anti-tau Alzheimer’s drug
If this proves successful, Roche will have the option to take over subsequent development or return the rights back to UCB.
-
AZ strengthens Daiichi Sankyo partnership with new ADC deal
Both companies will jointly develop and commercialise DS-1062 worldwide, apart from in Japan where Daiichi will retain exclusive rights.
-
Roche pays $775m upfront to access Blueprint’s RET programme
Expands on initial deal that is worth up to $1bn. Roche has expanded its existing collaboration with Blueprint Medicines, signing a new deal which will see it gain rights to the ... Roche will also have the right to opt in to a next-generation RET
-
Gilead and Arcus complete closing of ten-year immunotherapy partnership
This includes the immediate rights to zimberelimab, an investigational anti-PD-1 monoclonal antibody, as well as the right to opt-in to all of Arcus’ other current clinical candidates upon
More from news
Approximately 2 fully matching, plus 2,420 partially matching documents found.
Latest Intelligence
-
Gut instincts lead Takeda to GI pipeline success
The entire process has taught us the importance of thinking very differently, which matches very well with the way we’re structured right now,” adds Parikh.
-
Post-COVID-19 behaviour – the new normal or nothing new?
Once we’ve identified this, it’s about selecting the right intervention, which is derived from a set of evidence-based techniques. ... In essence, it’s about picking the right tool for the job.
-
The power of remote personal interactions: COVID-19 pandemic and the increasing role of remote engagement
Furthermore, of companies using or piloting remote interactions, more than 50% thought there was room for improvement or a need to do more, and only 5% thought they had it right. ... Individuals with the right listening and communication abilities need
-
Persuasive technology: designing behaviour change initiatives for digital
However, creating impactful virtual and online support tools (that are relevant, engaging, credible, trustworthy, timely and easy to use) relies on providers using the right content and technology for digital specific
-
Why pharma must trust the science of behaviour
Follow the evidence. Once again, such programmes rely on deep insight right from the start. ... But an effective model of consumption is one of the most important and challenging components to get right.
More from intelligence
Approximately 0 fully matching, plus 561 partially matching documents found.
Latest appointments
-
New faces at HCA, P\S\L Group and Health Unlimited
Joining as board chair is Alice Choi (pictured above, left), with Emma Kenny (pictured above, right) also joining as a board member and committee chair.
-
McCann Health London bolsters creative leadership team
Kieran Delaney (pictured right) joined McCann Health London in 2018 and has been promoted to deputy executive creative director.
-
McCann Health France strengthens team with two new hires
David-Basei (pictured right) has been appointed as medical director, and brings 20 years of experience of working for pharmaceutical and service companies to the team.
-
NICE looks internally for new chief executive
I am entirely confident that NICE will be safe and successful in her hand,” said Dillon (pictured right).
-
Pegasus gains a new managing director and digital lead
As managing director, Safeio has brought Jon Buckley (pictured right) to the team, who takes on the role of director of digital, strategy and insights.
More from appointments
Approximately 0 fully matching, plus 266 partially matching documents found.
Latest from PMHub
-
July 2020: diversity and inclusion in clinical trials round-up
So surely it is not right, that the majority of patients in Alzheimer’s disease trials over the past few decades, have all been white.
-
Medical Device Clinical Trials 2020
And partnering with these wellness apps can provide an opportunity to find and recruit the right participants.
-
The importance of health literacy in patient recruitment materials
Finding the right balance. Our findings show that it’s all about balance. ... A clinical trial is different to a product. It wouldn’t be right to not be fully informed from the get-go”.
-
Clark Health Communications and Egg digital announce new collaboration
This exciting alliance with Egg allows us to bring digital solutions right into the heart of our current thinking, planning and delivery but also to future proof our capability knowing that
-
Spirit
We ensure your meetings are memorable for the right reasons, employing bespoke digital solutions to enhance engagement and seamlessly connect people in multiple locations. ... format that is easily digestible and pitched at the right level.
More from PMHub
Approximately 0 fully matching, plus 490 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- US secures 100 million doses of Sanofi/GSK’s COVID-19 vaccine
- Gut instincts lead Takeda to GI pipeline success
- How will the events and exhibitions industry change post-Coronavirus?
- Novavax reports promising phase 1 results for coronavirus vaccine
- Gilead’s top-line slips 10% as demand for HIV/hepatitis C drugs drops
- A new era for patient services?
- J&J inks $1bn deal with US for coronavirus vaccine
- Novartis builds its case for novel MS treatment ofatumumab
- Pfizer’s Xalkori follow-up Lorbrena hits the mark in first-line lung cancer
- Award-winning agency Porterhouse Medical Group joins imc group with Waterland Private Equity’s support
- Live Webinar: Examining the Interface Between Healthcare & Society
- Novavax reports promising phase 1 results for coronavirus vaccine
PMHub
CSafe Global
CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...
Latest intelligence
- Virtual Engagement At Porterhouse: Reflections on the past few months
- ...
- July 2020: diversity and inclusion in clinical trials round-up
- COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest...
- Medical Device Clinical Trials 2020
- In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...
Quick links
Infographics
